Open Access | Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Factors associated with restenosis and postoperative complica- tions in patients undergoing buccal mucosal graft urethroplasty: retrospective analysis
* Corresponding author: Cláudia Sirlene Oliveira
Mailing address: Instituto de Pesquisa Pelé Pequeno Príncipe,
Faculdades Pequeno Príncipe, Curitiba (PR), Brazil.
Email: claudia.sirlene@professor.fpp.edu.br
Received: 24 February 2026 / Revised: 13 March 2026 Accepted: 24 March 2026 / Published: 31 March 2026
DOI: 10.31491/UTJ.2026.03.052
Abstract
Background: Urethral stenosis is a challenging urological condition, and its management includes a variety of
techniques broadly classified as endoscopic approaches or reconstructive procedures using graft urethroplasty. Buccal mucosal graft urethroplasty is currently considered the gold standard for the treatment of anterior
urethral stenosis. However, the literature remains inconclusive regarding the influence of patient-related factors on therapeutic success or failure, particularly with respect to restenosis. This study aimed to evaluate risk
factors for urethral restenosis and postoperative complications following buccal mucosal graft urethroplasty.
Methods: A retrospective review of medical records was conducted for patients with anterior urethral stenosis
who underwent buccal mucosal graft urethroplasty between September 2012 and December 2019 at a public
hospital in Curitiba, Paraná, Brazil.
Results: A total of 51 patients were included in the analysis. No statistically significant patient-related risk
factors for urethral restenosis were identified. However, a history of prior endoscopic prostate resection was
associated with an increased risk of postoperative complications following urethroplasty, and this association
was correlated with patient age.
Conclusion: These findings contribute to identifying factors associated with postoperative complications, facilitating improved preoperative risk stratification and patient counseling. Recognizing patients at higher risk
may enable clinicians to anticipate postoperative outcomes and tailor perioperative management after buccal
mucosal graft urethroplasty.
Keywords
Urethra, urethral stenosis, reconstructive surgery, buccal mucosal graft urethroplasty
Introduction
Male urethral stenosis is characterized by a narrowing of
the urethral lumen, most commonly resulting from fibrosis
or inflammatory processes [1]. This condition may arise
from multiple etiologies, including pelvic trauma, sexually transmitted infections, other infectious and inflammatory conditions, iatrogenic causes, hypospadias, prostate
cancer, radiotherapy, urethral calculi, prolonged urinary
catheterization, and idiopathic factors [2-5]. Additionally,
urethral stenosis can develop as a postoperative complication following surgical procedures, including transurethral
resection of the prostate (TURP), transvesical adenectomy, and radical prostatectomy [5]. Stenosis may affect any
segment of the urethra, including the prostatic, membranous, bulbar, and penile urethra, as well as the navicular
fossa or bladder neck. It may present as annular, short, or
long segments with varying degrees of associated inflammation [1].
Therapeutic strategies for urethral stenosis aim to reestablish adequate urinary flow and enhance quality of life.
Multiple surgical approaches are available, with treatment
selection guided by the size and complexity of the stenotic lesion. Internal urethrotomy is typically more effective
in cases of small or annular stenosis [1, 3, 6]. In contrast,
urethrectomy is preferred for stenosis shorter than 2 cm
associated with substantial fibrosis. In more complex
cases, graft urethroplasty is often indicated [3]. Buccal
mucosa is the preferred graft material, chosen over other
tissues such as skin, bladder epithelium, tunica vaginalis,
or intestinal mucosa because of its favorable characteristics, including excellent vascularity, ease of harvest, high
elastin content, and the absence of hair or other appendages [3, 7].
Reported long-term success rates for buccal mucosal graft
urethroplasty range from 73% to 93.3% [8-10]. Factors
influencing restenosis include obesity, smoking, alcohol
consumption, chronic comorbidities, age, previous urethral surgeries such as TURP, as well as the location, size,
and etiology of the stenosis [5, 10, 11]. In a meta-analysis,
Yoshikawa et al. [12] identified penobulbar location, stenosis length (> 7 cm), and diabetes mellitus as the main
risk factors for restenosis after a buccal mucosal graft
urethroplasty. Surgical decision-making should rely on the
best available evidence, established clinical guidelines,
and the surgeon’s expertise, while incorporating patientspecific characteristics into an individualized approach.
However, there is no consensus regarding which risk factors contribute to poor outcomes in stenosis correction
procedures. Therefore, when patient data are available,
it is possible to explore whether patient-related factors
identified during clinical assessment are associated with
restenosis and postoperative complications.
In this context, more robust scientific evidence is essential
to guide medical decision-making and optimize success
rates in buccal mucosal graft urethroplasty. Therefore,
this study aimed to identify risk factors for restenosis and
postoperative complications after buccal mucosal graft
urethroplasty, based on a small, single-center retrospective
analysis at a public hospital in Brazil.
Methods
A retrospective study was conducted extracting the target
data from the medical records of patients who underwent
urethroplasty with a buccal mucosal graft for the treatment of urethral stenosis (> 2 cm). Data from patients
who needed the use of combined surgical techniques (i.e.,
buccal mucosal graft urethroplasty combined with segmental urethrectomy, or the use of multiple graft types)
were not included. All procedures were performed at the
Urology Department of a public health service hospital
in Curitiba, Paraná, Brazil, between September 2012 and
December 2019. The study was approved by the Research
Ethics Committee of the public health hospital in Curitiba, Brazil (CAAE: 58826416.6.0000.0020; protocol no.
082136/2016).
The following variables were evaluated as potential predictors of outcome: stenosis size, anatomical location
(penile or bulbar), etiology, age, tobacco use, history of
prior procedures, and prior cystostomy. Postoperative
complications were recorded, along with the interventions
required for their management. Surgical success was defined as urethroplasty without the need for additional dilations and with satisfactory voiding patterns during a oneyear follow-up period. Continuous data are presented as
mean ± standard deviation (SD) for parametric variables
and as median with interquartile range for nonparametric
variables. Normality was assessed using the Shapiro–Wilk
test. Categorical data are expressed as frequencies and
percentages. Comparisons between stenosis size and age
were performed using Student’s t test or the Mann–Whitney U test, as appropriate. Associations between outcomes
and dichotomous categorical variables were evaluated
using 2 × 2 contingency tables, with odds ratios (ORs)
and 95% confidence intervals (CIs) calculated by crosstabulation. The chi-square (χ²) test was applied to identify
statistically significant associations, with results expressed
as Pearson’s χ² coefficient. Effect size was assessed using
Cramér’s V coefficient, with values ≤ 0.2 indicating weak,
0.2–0.6 moderate, and > 0.6 strong associations. A two-tailed P-value < 0.05 was considered statistically significant. All statistical analyses were performed using PASW
Statistics (SPSS) version 18 and GraphPad Prism version
8.4.2.
Results
A total of 51 patients who underwent urethroplasty with
a buccal mucosal graft were included in the retrospective analysis (Table 1). Among these, 13 patients (25.5%) developed restenosis within one year after the procedure. An
initial analysis was performed to evaluate the association
between restenosis and potential risk factors (Table 2).
No statistically significant associations were identified for
smoking status or for stenosis etiology, including trauma,
infection, prior urinary catheterization, previous transurethral surgery, or idiopathic causes. The use of cystostomy
for urinary obstruction was not statistically associated
with an increased risk of restenosis. Likewise, no higher
incidence of restenosis was observed among patients with
a history of prior urethral surgery. In both scenarios, including analyses stratified by stenosis size, no significant
risk factors for restenosis were identified.
In the second stage of evaluation, we calculated the same
parameters while analyzing the risk of postoperative complications (Table 3). In this stage, we found that patients
who had undergone previous TURP had an increased risk
of postoperative complications. A total of seven cases of complications were observed in the TURP group, including one case of infection with penoscrotal abscess, two
cases of hematomas, one case of urethral infection, and
two cases of urinary tract infections.
Table 1.
Characteristics of the study population.
| Patients’ characteristics | All | No restenosis | Restenosis |
|---|---|---|---|
| Number of participants (%) | 51 | 38 (74.5%) | 13 (25.5%) |
| Age (years) (%) | 55.43 ± 14.88 | 56.16 ± 14.65 | 53.31 ± 15.96 |
| Stenosis size (cm) (%) | 6.775 ± 4.399 | 6.303 ± 4.078 | 8.154 ± 5.157 |
| Smoker (%) | 6 (11.8) | 5 (13.2) | 1 (7.7) |
| Stenosis cause | |||
| Trauma (%) | 10 (19.6) | 7 (18.4) | 3 (23.1) |
| Infection (%) | 17 (33.3) | 12 (31.6) | 5 (38.5) |
| Urinary catheter (%) | 9 (17.6) | 7 (18.4) | 2 (15.4) |
| TURP (%) | 7 (13.7) | 4 (10.5) | 3 (23.1) |
| Idiopathic (%) | 9 (17.6) | 8 (21.1) | 1 (7.7) |
| Cystostomy | 17 (33.3) | 12 (31.6) | 5 (38.5) |
| Previous procedure | |||
| Dilatation (%) | 7 (13.7) | 5 (13.2) | 2 (15.4) |
| Urethrotomy (%) | 11 (21.6) | 6 (15.8) | 5 (38.5) |
Note: TURP: transurethral resection of the prostate.
Table 2.
Odds ratio estimation for factors associated with restenosis.
| Factor | OR | CI 95% | P-value | Pearson’s χ² | Cramér’s V | |
|---|---|---|---|---|---|---|
| Smoker | 0.550 | 0.058 | 5.199 | 0.598 | 0.279 | 0.073 |
| Former smoker | 0.708 | 0.072 | 6.981 | 0.767 | 0.088 | 0.042 |
| Trauma | 1.329 | 1.329 | 6.128 | 0.715 | 0.133 | 0.051 |
| Infection | 1.354 | 0.365 | 5.019 | 0.650 | 0.206 | 0.064 |
| Urinary catheter | 0.805 | 0.145 | 4.476 | 0.804 | 0.061 | 0.035 |
| TURP | 2.550 | 0.487 | 13.340 | 0.256 | 1.288 | 0.159 |
| Idiopathic | 0.313 | 0.035 | 2.776 | 0.275 | 1.190 | 0.153 |
| Cystostomy | 1.302 | 0.351 | 4.837 | 0.693 | 0.156 | 0.056 |
| Previous urethral surgery | 2.174 | 0.513 | 9.221 | 0.286 | 1.140 | 0.150 |
| Stenosis size (small: < 4 cm) | 0.494 | 0.129 | 1.884 | 0.297 | 1.088 | 0.146 |
| Stenosis size (medium: 4-8 cm) | 2.014 | 0.525 | 7.726 | 0.303 | 1.062 | 0.144 |
| Stenosis size (large: > 8 cm) | 1.091 | 0.277 | 4.296 | 0.901 | 0.015 | 0.017 |
Note: TURP: transurethral resection of the prostate.
Table 3.
Odds ratio estimation for factors associated with postoperative complications (i.e., urethral infection, urinary tract infection, purulent
drainage, penoscrotal abscess, and hematoma).
| Factor | OR | CI 95% | P-value | Pearson’s χ² | Cramér’s V | |
|---|---|---|---|---|---|---|
| Smoker | 1.300 | 0.129 | 13.132 | 0.824 | 0.050 | 0.031 |
| Infection | 0.773 | 0.134 | 4.469 | 0.774 | 0.083 | 0.040 |
| TURP | 7.500 | 1.220 | 46.096 | 0.016 * | 5.815 | 0.338 |
| Idiopathic | 0.750 | 0.079 | 7.125 | 0.802 | 0.63 | 0.035 |
| Cystostomy | 0.350 | 0.038 | 3.265 | 0.339 | 0.913 | 0.135 |
| Previous urethral surgery | 3.778 | 0.418 | 34.172 | 0.210 | 1.568 | 0.175 |
| Stenosis size (small: < 4cm) | 0.987 | 0.197 | 4.944 | 0.987 | 0.000 | 0.002 |
| Stenosis size (medium: 4-8 cm) | 2.250 | 0.434 | 11.659 | 0.325 | 0.967 | 0.138 |
| Stenosis size (large: > 8 cm) | 0.357 | 0.039 | 3.256 | 0.344 | 0.894 | 0.132 |
Note: * indicates statistical significance.
In the third stage, stenosis size was compared between patients with and without restenosis. Additionally, stenosis
size was evaluated according to the occurrence of other
complications and prior surgical history (Figure 1). No
statistically significant differences were observed among
the evaluated parameters. In the final stage, patient age
was compared between those who developed restenosis
and those who did not (Figure 2), and no statistically significant difference was detected between the groups.
Furthermore, we evaluated whether patient age differed
between those who underwent stenosis correction and
developed the complication of TURP and those who did
not. A statistically significant age difference was observed
between the two groups (Figure 3; unpaired t-test, P <
0.05; t = 3.62, df = 49), suggesting that the occurrence of
this complication may be associated with patient age at
the time of stenosis correction.

Figure 1. Stenosis size in patients with restenosis (A) and complications (B) compared to patients without these outcomes, and stenosis size in patients who underwent prior surgery compared to those without previous surgery (C).

Figure 2. Age range comparison between patients with restenosis (A) and complications (B) versus patients without these outcomes.

Figure 3. Age range comparison between patients with transurethral prostate resection (TURP) and patients without this outcome (No-TURP). * indicates a statistically significant difference compared to the group without the outcome.
Discussion
Although treatment strategies for urethral stenosis are well
established, the factors contributing to restenosis are not
completely understood. Considerable controversy persists
regarding potential risk factors, including hypertension,
diabetes mellitus, coronary artery disease, smoking, prior
surgical interventions, as well as the length and anatomical location of the stenosis [10-14]. The heterogeneity of
existing studies and the variability in patient populations
impair the proper identification of consistent predictors of
restenosis.
Obesity and smoking are frequently reported as factors
potentially associated with increased failure rates following urethroplasty due to urethral stenosis [15, 16]. Smoking, particularly when combined with poor oral hygiene,
may impair wound healing and negatively affect graft
quality [16]. Additionally, diabetes mellitus and tobacco
use are known to promote microvascular damage, which
may compromise tissue repair and healing after urethroplasty [14, 16, 17]. However, in our study, no significant
association was observed between smoking and urethral
stricture recurrence. Similarly, in a cohort of 596 patients
undergoing urethroplasty (40.3% buccal mucosal graft
urethroplasty), Chapman et al. [10] reported that smoking was not independently associated with stenosis recurrence
on multivariate analysis. These findings are consistent
with a previous meta-analysis conducted by our research
group [12].
Our cohort comprised middle-aged to elderly patients,
with a mean age of 55 years. Spilotros et al. [18] reported
a significant association between age and surgical outcomes following various forms of buccal mucosal graft
urethroplasty. Their findings demonstrated superior results
in younger patients, with a recurrence rate of 6.3% in individuals under 30 years of age, compared with 15.2% in
those aged 31–50 years and 35.1% in patients older than
50 years. While the literature report that urethral strictures
are most commonly reported in elders [19], our analysis
did not find the same association. These discrepancies
may reflect differences in patient selection, the range of
patient’s age included in the study, comorbidity profiles,
or methodological variations between studies, highlighting the ongoing uncertainty regarding the role of age as
an independent predictor of urethroplasty success. Breyer
et al. [11] also reported increased age as a risk factor for
restenosis. Similarly, our retrospective analysis of urethral
stenosis secondary to TURP demonstrated that older age
was significantly associated with a higher incidence of
complications. These findings suggest that impaired urethral vascularization, combined with age-related microvascular alterations, may contribute to poorer outcomes in
older patients.
One of the major controversies in the literature is whether
stenosis etiology influences the risk of urethral restenosis.
Inflammatory etiology has often been suggested as an
independent risk factor for recurrence [10, 14]. However,Spilotros et al. [18] did not confirm this association in
their multivariate analysis. Similarly, in agreement with
both Spilotros et al. [18] and the meta-analysis conducted
by our research group [12], our study did not detected a
statistically significant association between inflammatory
etiology and higher recurrence rates. Taken together, these
findings suggest that etiology alone may not be a reliable
predictor of surgical success following urethroplasty.
Several studies suggest that prior urethral interventions,
including urethroplasty and endoscopic procedures such
as direct visual internal urethrotomy or dilation, may
serve as independent predictors of urethral stricture recurrence [10, 11, 20]. In the present study, however, previous endoscopic treatment or dilation was not associated
with increased restenosis rates. Although not routinely
recommended as definitive conduct, this finding suggests
that endoscopic interventions may be used as temporary
measures without negatively impacting outcomes following subsequent urethroplasty. Conversely, the higher
recurrence risk observed in patients with a history of prior
urethral reconstruction may be related to extensive fibrosis and ischemic changes at the stricture site, which can
compromise tissue quality and surgical success [5].
Previous urethroplasty has been identified as a predictive factor for recurrence in some studies [5]; however, in
agreement with our previous meta-analysis [12], our findings did not demonstrate adverse effects of prior urethroplasty on restenosis after repeat intervention. These discrepancies across studies may reflect differences in patient
selection, surgical techniques, or definitions of treatment
success.
Stricture length has also been proposed as an important
determinant of surgical outcomes. Success rates for buccal
mucosal grafting appear to decrease in strictures longer
than 7 cm, potentially due to compromised vascular supply and challenges in graft integration. We previously
reported in a meta-analysis study [12] lower success rates
in extensive strictures (> 7 cm), while shorter strictures
were identified as a protective factor against recurrence.
This meta-analysis demonstrated statistical significance
for a mean stricture length of approximately 7 cm as a
threshold associated with restenosis risk. In contrast, our
analysis did not identify stricture length as a significant
predictor, even when subdividing cases into groups at 4-cm
intervals.
Notably, a history of prior endoscopic prostate resection
was associated with an increased risk of postoperative
complications following urethroplasty, and this association
appeared to correlate with patient age. In our retrospective cohort, previous prostate resection was significantly
associated with higher complication rates. We postulate
that this relationship stems from the use of larger-caliber
instrumentation in urethras with already compromised
vascularity, particularly in cases of prostatic enlargement
where procedural duration is often prolonged. We hypothesize that prolonged instrumentation induces transient
ischemia through radial compression exceeding capillary perfusion pressure, thereby triggering microvascular
injury and subsequent fibrotic remodeling. Consistent with this hypothesis, El-Kassaby et al. [21] identified
inflammation and ischemia as independent risk factors
for restenosis. In elderly patients, whose vascular reserve
is already diminished by age-related changes, such ischemic insults may accelerate spongiofibrosis through the
replacement of elastic tissue with dense collagen. Thermal
effects from resectoscopic energy may further exacerbate
local tissue injury.
This study reflects the experience of a single surgeon in
a teaching hospital setting with resident participation and
a moderate volume of urethroplasty procedures. Several
important limitations must be acknowledged. First, the
retrospective design and relatively small sample size limit
the statistical power of the analysis and increase the risk
of type II error, restricting the ability to detect true associations. In addition, the single-center nature of the study
and the involvement of a single surgeon may limit the
generalizability of the findings. The absence of a standardized follow-up protocol may have introduced variability
in outcome assessment. Furthermore, the study lacked detailed information on the control and severity of comorbid
conditions, such as hypertension and diabetes mellitus,
which may act as important confounders. Given these
constraints, the findings, particularly any observed associations, should be interpreted with caution and should not
be considered definitive evidence of causal relationships,
but rather as exploratory signals that warrant confirmation
in larger, adequately powered prospective studies.
Conclusions
This retrospective analysis demonstrates that anterior urethroplasty using a buccal mucosal graft remains an effective treatment for urethral strictures, yielding favorable outcomes and a low overall recurrence rate. However, a history of prior TURP emerged as a significant risk factor for postoperative complications. Critically, within this specific TURP subgroup, advanced age was further associated with a heightened complication rate, a correlation that was not observed in the broader study population. These findings suggest that elderly patients with a history of prostate resection represent a high-risk phenotype, particularly susceptible to infectious complications and hematomas. Consequently, this subset may require more rigorous perioperative antibiotic protocols and vigilant vascular monitoring to mitigate their unique risk profile. Prospective studies are warranted to further evaluate the role of potentially modifiable risk factors and to assess their impact on long-term outcomes following urethroplasty with buccal mucosal grafts.
Declarations
Acknowledgments
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, Funda- ção Araucária - Secretaria de Ciência, Tecnologia e Ensino Superior and the Instituto de Pesquisa Pelé Pequeno Príncipe (IPPPP).
Author contributions
Conceptualization: Gustavo Bono Yoshikawa and Cláudia Sirlene Oliveira; investigation: Gustavo Bono Yoshikawa, Gabriella Giandotti Gomar, Giovanna Ceccatto Gadens, and Beatriz França Zanetti Saes; data curation: Quelen Iane Garlet; writing – original draft: Gustavo Bono Yoshikawa and Henrique Burger; writing – review & editing: Quelen Iane Garlet and Cláudia Sirlene Oliveira.
Availability of data and materials
All the data are presented in the results section.
Financial support and sponsorship
None.
Conflicts of interest
The authors declare that they have no competing interests regarding the publication of this paper. All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript.
Ethical approval and informed consent
The study was approved by the Research Ethics Committee of the public health hospital in Curitiba, Brazil (CAAE: 58826416.6.0000.0020; protocol no. 082136/2016).
References
1. Wein A, Kavoussi L, Novick A, Partin A, & CA P (2012). Campbell-Walsh Urology, Elsevier Saunders.
2. Romero Pérez P, & Mira Llinares A. Male urethral stenosis: review of complications. Arch Esp Urol, 2004, 57(5): 485-511.
3. Wessells H, Angermeier K, Elliott S, Gonzalez C, Kodama R, Peterson A, et al. Male urethral stricture: American Urological Association guideline. J Urol, 2017, 197(1): 182-190. [Crossref]
4. Baradaran N, Hampson L, Edwards T, Voelzke B, & Breyer B. Patient-reported outcome measures in urethral reconstruction. Curr Urol Rep, 2018, 19(7): 48-59. [Crossref]
5. Shalkamy O, Abdelazim H, Elshazly A, Soliman A, Agha M, Tagreda I, et al. Factors predicting urethral stricture recurrence after dorsal onlay augmented buccal mucosal graft urethroplasty. Urol Int, 2021, 105(3-4): 269-277. [Crossref]
6. Peixoto G, Sakuramoto P, & Lima T. Abordagem contemporânea da estenose de uretra. 2017, 7: 18-21.
7. Markiewicz M, Lukose M, Margarone J, 3rd, Barbagli G, Miller K, & Chuang S. The oral mucosa graft: a systematic review. J Urol, 2007, 178(2): 387-394. [Crossref]
8. Barbagli G, Morgia G, & Lazzeri M. Retrospective outcome analysis of one-stage penile urethroplasty using a flap or graft in a homogeneous series of patients. BJU Int, 2008, 102(7): 853-860. [Crossref]
9. Barbagli G, Kulkarni S, Fossati N, Larcher A, Sansalone S, Guazzoni G, et al. Long-term followup and deterioration rate of anterior substitution urethroplasty. J Urol, 2014, 192(3): 808-813. [Crossref]
10. Chapman D, Kinnaird A, & Rourke K. Independent predictors of stricture recurrence following urethroplasty for isolated bulbar urethral strictures. J Urol, 2017, 198(5): 1107-1112. [Crossref]
11. Breyer B, McAninch J, Whitson J, Eisenberg M, Mehdizadeh J, Myers J, et al. Multivariate analysis of risk factors for long term urethroplasty outcome. J Urol, 2010, 183(2): 613-617. [Crossref]
12. Yoshikawa G, Gomar G, Gadens G, Saes B, Galiciolli M, Pereira M, et al. Re-stricture after buccal mucosal graft urethroplasty: a systematic review and meta-analysis. Acta Cir Bras, 2025, 40: e403525. [Crossref]
13. Han J, Liu J, Hofer M, Fuchs A, Chi A, Stein D, et al. Risk of urethral stricture recurrence increases over time after urethroplasty. Int J Urol, 2015, 22(7): 695-699. [Crossref]
14. Kinnaird A, Levine M, Ambati D, Zorn J, & Rourke K. Stricture length and etiology as preoperative independent predictors of recurrence after urethroplasty: a multivariate analysis of 604 urethroplasties. Can Urol Assoc J, 2014, 8(5-6): E296-300. [Crossref]
15. Ekerhult T, Lindqvist K, Peeker R, & Grenabo L. Limited experience, high body mass index and previous urethral surgery are risk factors for failure in open urethroplasty due to penile strictures. Scand J Urol, 2015, 49(5): 415-418. [Crossref]
16. Sinha R, Singh V, & Sankhwar S. Does tobacco consumption influence outcome of oral mucosa graft urethroplasty? Urol J, 2010, 7(1): 45-50.
17. Figler B, Malaeb B, Dy G, Voelzke B, & Wessells H. Impact of graft position on failure of single-stage bulbar urethroplasties with buccal mucosa graft. Urology, 2013, 82(5): 1166-1170. [Crossref]
18. Spilotros M, Sihra N, Malde S, Pakzad M, Hamid R, Ockrim J, et al. Buccal mucosal graft urethroplasty in menrisk factors for recurrence and complications: a third referral centre experience in anterior urethroplasty using buccal mucosal graft. Transl Androl Urol, 2017, 6(3): 510-516. [Crossref]
19. Santucci R, Joyce G, & Wise M. Male urethral stricture disease. J Urol, 2007, 177(5): 1667-1674. [Crossref]
20. Kessler T, Schreiter F, Kralidis G, Heitz M, Olianas R, & Fisch M. Long-term results of surgery for urethral stricture: a statistical analysis. J Urol, 2003, 170(3): 840-844. [Crossref]
21. el-Kasaby A, el-Baz M, & el-Zayat T. Eversion meatoplasty in management of urethral meatal stenosis. Int Urol Nephrol, 1996, 28(2): 229-233. [Crossref]